ATAI Life Sciences Announces Neuronasal Completes Pilot Study, Receives IND Clearance to Continue into Phase I Trials of mTBI Therapeutic Post published:October 27, 2020 Post category:Press Release
Hollister Biosciences Inc. Provides Update on Q3 2020 Performance Post published:October 27, 2020 Post category:Press Release
MAPS Study: MDMA-Assisted Psychotherapy Will Be More Cost-Effective than Other Treatments for PTSD Post published:October 27, 2020 Post category:Press Release
NeonMind Manufactures 4 Superfood Mushroom Coffees Post published:October 27, 2020 Post category:Press Release
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 Post published:October 26, 2020 Post category:Press Release
COMPASS Pathways plc to ring Nasdaq Stock Exchange opening bell in celebration of its successful $146.6 million IPO Post published:October 26, 2020 Post category:Press Release
Field Trip Health Ltd. Continues Expansion With Psychedelic-Enhanced Therapy Center in Chicago Post published:October 22, 2020 Post category:Press Release
Numinus First Canadian Public Company to Complete Legal Harvest of Psilocybe Mushrooms Post published:October 22, 2020 Post category:Press Release
Pharmather Secures Exclusive Rights to Novel Microneedle Delivery Technology for Psychedelic Pharmaceuticals Post published:October 22, 2020 Post category:Press Release
Thoughtful Brands Finalizes Deal to Acquire American CBD Extraction Corp. Post published:October 22, 2020 Post category:Press Release